-
Market Wrap For January 8: Fed Minutes Released
Wednesday, January 8, 2014 - 5:39pm | 2250Read More...Major indices finished Wednesday's trading session relatively flat as the Fed's minutes released had no impact on the markets. Minutes released from the Federal Reserve's latest meeting re-affirmed that many members on the committee wanted to proceed with caution in trimming the $85 billion...
-
Brean Murray Reiterates Buy Rating On NPSP
Thursday, April 28, 2011 - 8:10am | 62Read More...Brean Murray is reiterating its Buy rating on shares of NPS Pharmaceuticals, Inc. (NASDAQ: NPSP). “Although there are no additional presentations directly related to Gattex during the 2011 DDW conference, we draw investor attention to several abstracts related to other GLP-2 analog, such as FE...
-
Jefferies Reports On NPS Pharmaceuticals Study (NPSP)
Monday, March 28, 2011 - 7:15am | 69Read More...Jefferies has issued a report on a two-year animal study by NPS Pharmaceuticals (NASDAQ: NPSP). According to the report, "In a 2-year animal carcinogenicity study, teduglutide (Gattex) was found to be neither carcinogenic nor a tumor promoter at doses up to 700 times the clinical dose (0.05 mg/kg/...
-
Jefferies Reiterates Buy on NPS Pharmaceuticals (NPSP)
Wednesday, March 16, 2011 - 8:50am | 87Read More...Jefferies is out with its report today on NPS Pharmaceuticals (NASDAQ: NPSP), reiterating Buy. In a note to clients, Jefferies writes, "We view NPSP as a significantly de-risked story following 2nd confirmatory Gattex Ph3 data, but it's currently trading below the levels prior to the Ph3 data....
